Abstract
ABri is a 34 residue polypeptide that forms amyloid fibrils in Familial British Dementia (FBD). A PSI-Blast search, 3 different fold recognition programs and 3D model-building indicated that it has 3 beta-strands forming an antiparallel beta-sheet and a small C-terminal alpha-helix. In order to validate the prediction, the region coding the ABri polypeptide was cloned, expressed and purified from E.Coli. Circular Dichroism (CD) spectroscopy of ABri in aqueous solution shows it to have a predominantly beta-sheet structure with a small alpha-helical component.
Keywords: ABRI AMYLOID SUBUNIT, AMYLOIDOGENESIS, FAMILIAL BRITISH DEMENTIA, human homologue (BRi), ABri amyloid polypeptide
Protein & Peptide Letters
Title: Predicted fold for the ABri Amyloid Subunit: A Model for Amyloidogenesis in Familial British Dementia.
Volume: 8 Issue: 3
Author(s): Daruka Mahadevan, Tapan Chattopadhyay, Rex A. Palmer, Ronan O Brien and Jose W. Saldanha
Affiliation:
Keywords: ABRI AMYLOID SUBUNIT, AMYLOIDOGENESIS, FAMILIAL BRITISH DEMENTIA, human homologue (BRi), ABri amyloid polypeptide
Abstract: ABri is a 34 residue polypeptide that forms amyloid fibrils in Familial British Dementia (FBD). A PSI-Blast search, 3 different fold recognition programs and 3D model-building indicated that it has 3 beta-strands forming an antiparallel beta-sheet and a small C-terminal alpha-helix. In order to validate the prediction, the region coding the ABri polypeptide was cloned, expressed and purified from E.Coli. Circular Dichroism (CD) spectroscopy of ABri in aqueous solution shows it to have a predominantly beta-sheet structure with a small alpha-helical component.
Export Options
About this article
Cite this article as:
Mahadevan Daruka, Chattopadhyay Tapan, Palmer A. Rex, O Brien Ronan and Saldanha W. Jose, Predicted fold for the ABri Amyloid Subunit: A Model for Amyloidogenesis in Familial British Dementia., Protein & Peptide Letters 2001; 8 (3) . https://dx.doi.org/10.2174/0929866013409472
DOI https://dx.doi.org/10.2174/0929866013409472 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Voxel-Based Morphometry of the Human Brain: Methods and Applications
Current Medical Imaging Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies
CNS & Neurological Disorders - Drug Targets Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis
Current Alzheimer Research Withaferin A Regulates LRRK2 Levels by Interfering with the Hsp90- Cdc37 Chaperone Complex
Current Aging Science Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Current Diabetes Reviews Editorial (Thematic Issue: “Infectious Diseases in Asia-Pacific: Historical and Contemporary Perspectives”)
Infectious Disorders - Drug Targets Mediterranean Diet and Risk of Dementia
Current Alzheimer Research Cytoskeletal Integrity as a Drug Target
Current Alzheimer Research HIV1-Human Protein-Protein Interaction Prediction (HHPPIP) Methodology: An FP-Growth Based Association Rule Mining Approach
Current Bioinformatics Cellular Protection and Therapeutic Potential of Tocotrienols
Current Pharmaceutical Design A Pilot Study of Exenatide Actions in Alzheimer’s Disease
Current Alzheimer Research The Role of Pericytes in Neurovascular Unit: Emphasis on Stroke
Current Drug Targets Amyloid-β Immunotherapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Cannabinoids and Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic:Perspective on Mild Cognitive Impairment (MCI) (Guest Editor: Bernardino Ghetti)]
Current Alzheimer Research A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
Current Drug Metabolism Neurodegeneration in Amygdala Precedes Hippocampus in the APPswe/ PS1dE9 Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Hypertension and Ischemic Heart Disease in Women
Current Pharmaceutical Design In Silico Screening of Drugs to Find Potential Gamma-Secretase Inhibitors Using Pharmacophore Modeling, QSAR and Molecular Docking Studies
Combinatorial Chemistry & High Throughput Screening A Conceptual Framework for Research on Cognitive Impairment with no Dementia in Memory Clinic
Current Alzheimer Research